SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for battling Brain-Invading lymphoma
Disease control OngoingThis study is testing a combination of six drugs, called TEDDI-R, to treat aggressive B-cell lymphoma that has spread to the central nervous system (brain, spinal cord, or eyes). The goal is to see if this new regimen can better control the cancer and help patients live longer wi…
Matched conditions: SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Experimental Four-Target antibody tested for tough brain cancers
Disease control OngoingThis early-stage study is testing a new, four-target antibody drug called GNC-038 in adults with primary or secondary brain lymphoma that has come back or hasn't responded to other treatments. The main goals are to find a safe dose, understand how the body processes the drug, and…
Matched conditions: SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC